![| A02 |](https://letsimmun.de/wp-content/uploads/2022/01/A02.jpg)
| A02 |
Title One CAR – multiple antigens: Universal CAR-T that are chemically programmed to recognize tumorsTitle
![|A06|](https://letsimmun.de/wp-content/uploads/2022/02/A06-1-400x284.jpg)
|A06|
Title Engineering CAR-T cells against neuroblastoma with synthetic notch receptors to increase tumor-specificity and endogenous immune activationTitle
![|B03|](https://letsimmun.de/wp-content/uploads/2022/02/B03-400x284.jpg)
|B03|
Title Engineering tissue-resident lymphocytes for the modulation of tissue-microenvironmentsTitle
![|B05|](https://letsimmun.de/wp-content/uploads/2022/02/B05-400x284.jpg)
|B05|
Title Engineering of CAR-T cells that overcome MYC-dependent immunosuppression in a genetically engineered mouse model of pancreatic cancerTitle
![|C01|](https://letsimmun.de/wp-content/uploads/2022/02/C01-400x284.jpg)
|C01|
Title Exploitation of negative regulators of TCR signaling for therapeutic lymphocyte engineerinTitle
![|C02|](https://letsimmun.de/wp-content/uploads/2022/02/Scheme_C02-project-400x284.png)
|C02|
Title Post-transcriptional control of metabolic programs that improve T cell responses against tumors Title
![|C03|](https://letsimmun.de/wp-content/uploads/2022/02/C03.jpg)
|C03|
Title Targeting T cell-intrinsic negative regulators to enhance the therapeutic potential of adoptive T cell therapyTitle
![|C04|](https://letsimmun.de/wp-content/uploads/2022/02/C04.jpg)
|C04|
Title Dissection and correction of human regulatory T cell dysfunctions by CRISPR engineeringTitle
![|C05|](https://letsimmun.de/wp-content/uploads/2022/02/C05.jpg)
|C05|
Title Metabolic reprogramming to optimize the cellular fitness and function of engineered T cellsTitle
Contact Details
Dr. Magdalena Nauerth
Trogerstr.30
81675 München
+4989 4140 6887